Western Pallet Magazine November 2024 | Page 35

November 2024

How does a Trump presidency change the outlook of the US pallet market?

As a newly re-elected President Trump prepares to reshape US economic policy, the US  pallet market faces a blend of opportunity and uncertainty. Here’s how key policies and proposed shifts in trade, immigration,  housing  and economic regulation could impact the industry over the coming term.

Four ways Trump could impact the agriculture sector during second term

In a return to the White House, President-elect Donald Trump has vowed to overturn climate regulations and deregulate the agriculture industry. 

US South Set to Surpass Canada in Lumber Production

The U.S. South is poised to overtake Canada’s historic dominance in North American lumber production as decades of trade restrictions take their toll.

A Deep Dive into AB 98’s Restrictions on the Logistics Industry: What the Bill Does and Does Not Do

Despite strenuous opposition from both the state’s real estate and business communities,  near the end of the 2024 Legislative cycle, California Governor Gavin Newsom signed into law Assembly Bill 98 (“AB 98”) – a bill that, among other things, creates buffer zones and imposes other statewide design and build standards around new warehouse development.

Major Guardian Packaging Expansion Announced by Conner Industries

Conner Industries, Inc., a leading provider of lumber, industrial wood crates and pallets, and integrated protective packaging solutions, including corrugate, foam, and plastics, has announced the expansion of its Guardian Packaging facility in Dallas, Texas.

Is Big Pharma Focusing More on US-Based Manufacturing?

Amgen's billion-dollar US investments in manufacturing and packaging are the latest infusion of Big Pharma "Made-in-America” dollars. Experts weigh on the trend's costs, benefits, and industry prognosis.

Amgen's billion-dollar US investments in manufacturing and packaging are the latest infusion of Big Pharma "Made-in-America” dollars. Experts weigh on the trend's costs, benefits, and i Big Pharma "Made-in-America” dollars.